Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas

Endocrine Pathology

Volumn 12, Issue 2, 2001, Pages 181-188

  Komatsubara, Kiyoteru ^a,b   Tahara, Shigeyuki ^a,b   Umeoka, Katsuya ^a,b   Sanno, Naoko ^b   Teramoto, Akira ^b   Osamura, R Yoshiyuki ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cell proliferation; Cyclin dependent kinase (CDK) inhibitor; p27; Pituitary adenoma

Indexed keywords

CORTICOTROPIN; CYCLIN DEPENDENT KINASE; GROWTH HORMONE; MONOCLONAL ANTIBODY; PROLACTIN; PROTEIN P27; THYROTROPIN;

ANTIGEN RETRIEVAL; ARTICLE; ENZYME INHIBITION; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR GROWTH;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMAN GROWTH HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; PROLACTINOMA; THYROTROPIN; TUMOR SUPPRESSOR PROTEINS;

EID: 0034824372     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:12:2:181     Document Type: Article

References (32)

1. Differential interaction of the cyclin-dependent kinase(Cdk) inhibitor p27 Kip1 with Cyclin A-Cdk2 and Cyclin D2-Cdk4
2. Cell cycle-mediated regulation of hepatic regeneration
3. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female ste- rility in p27(Kip1)-deficient mice
4. Cyclin-dependent kinase inhibitor p27 kip1 is expressed at high levels in cells that express a myelinating phenotype
5. Biphasic regulation of breast cancer cell growth by progesterone: Role of the cycline-dependent kinase inhibitors, p21 and p27 (Kip1)
6. Cdk inhibitors in development and cancer
7. Heterozygous Rb-1 δ20/ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance
8. Molecular analysis of p21 and p27 genes in human pituitary adenomas
9. Effect of cyclin D1 overexpression on G1 progression-related events
10. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27 Kip1 expression in nontumorous and neoplastic human pituitaries
11. Reduced levels of the cell-cycle inhibitor p27(Kip1) in epithelial dysplasia and carcinoma of the oral cavity
12. Expression of cyclin D1, CDK4 and p27 KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines
13. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27 (Kip1)
14. Progression of LNCaP prostate tumor cells during androgen deprivation: Hormone-independent growth, repression of proliferation by androgen, and role for p27(Kip1) in androgen-induced cell cycle arrest
15. New functional activities for the p21 family of CDK inhibitors
16. Low expression of the cell cycle inhibitor p27 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumor
17. Aberrant p27(kip1) expression in endocrine and other tumors
18. TGF β, TGF β receptors, Ki-67, and p27(kip1) expression in papillary thyroid carcinomas
19. Principles of CDK regulation
20. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
21. Cloning and characterization of rat p27 Kip1, a cyclin-dependent kinase inhibitor
22. p27 Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
23. Expression of D-type cyclins in normal and neoplastic rat pituitary
24. Transforming growth factor-beta and p27 expression in pituitary cells
25. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma
26. Hormone-induced proliferation and differentiation of granulosa cells: A coordinated balance of the cell cycle regulators cyclin D2 and p27(Kip1)
27. Cyclin-dependent kinase inhibitor p27 KIP1 in lymphoid tissue: p27 KIP1 expression is inversely proportional to the proliferative index
28. G1 phase progression: Cycling on cue
29. Activation of the various cyclin/ cdc2 protein kinases
30. Infrequent mutations of p27(Kip1)gene and trisomy 12 in a subset of human pituitary adenomas
31. p27, a novel inhibitor of G1 Cyclin-Cdk protein kinase activity, is related to p21
32. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences